FOxTROT: Randomized phase II study of neoadjuvant chemotherapy (CT) with or without an anti-EGFR monoclonal antibody for locally advanced, operable colon cancer: Planned interim report (JOURNAL OF CLINICAL ONCOLOGY, 2011)

(untitled) - Morton, D; Magill, L; Handley, K; Brown, G; Ferry, DR; Gray, Z; Quirke, P; Seymour, M; Warren, B; Gray, R; Grp, F